CONMED (NYSE:CNMD) Updates FY 2025 Earnings Guidance

CONMED (NYSE:CNMD) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 4.250-4.400 for the period, compared to the consensus earnings per share estimate of 4.740. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

Analysts Set New Price Targets

A number of research firms have recently issued reports on CNMD. StockNews.com lowered shares of CONMED from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Needham & Company LLC restated a “buy” rating and issued a $97.00 price objective on shares of CONMED in a report on Thursday, October 31st. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $79.80.

CONMED Stock Performance

CNMD stock traded up $1.47 during midday trading on Wednesday, reaching $74.35. The company had a trading volume of 573,352 shares, compared to its average volume of 415,094. CONMED has a fifty-two week low of $61.05 and a fifty-two week high of $88.60. The company has a quick ratio of 1.06, a current ratio of 2.27 and a debt-to-equity ratio of 1.01. The stock has a 50 day moving average price of $70.62 and a 200 day moving average price of $70.19. The firm has a market capitalization of $2.30 billion, a PE ratio of 17.66, a P/E/G ratio of 1.04 and a beta of 1.46.

CONMED (NYSE:CNMD) last released its earnings results on Wednesday, February 5th. The company reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. CONMED had a return on equity of 13.84% and a net margin of 10.23%. Analysts anticipate that CONMED will post 4.03 earnings per share for the current year.

CONMED Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 3rd. Investors of record on Friday, December 20th were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, December 20th. This represents a $0.80 annualized dividend and a dividend yield of 1.08%. CONMED’s payout ratio is 19.00%.

CONMED Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.